Your session is about to expire
← Back to Search
Acoustic Stimuli for Spinal Cord Injury
N/A
Waitlist Available
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 18-75 years
Chronic SCI (≥1 year of injury)
Must not have
History of head injury or stroke
Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, or herniated cervical disk
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 hours
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers understand how the body changes neurologically after a Spinal Cord Injury, which will in turn help patients with SCIs learn to live with their injury.
Who is the study for?
This trial is for adults aged 18-75 with chronic incomplete spinal cord injury at T12 or above, who've had the injury for over a year. Participants should be able to move their elbow, knee, or ankle voluntarily and grasp objects. It's not suitable for those with uncontrolled medical issues, major depression/psychosis before SCI, history of head injury/stroke/seizures, metal in the skull, pacemaker users, pregnant women or people on certain CNS drugs.
What is being tested?
The study investigates how acoustic stimuli (Startle) can affect muscle stiffness (spasticity) after spinal cord injuries (SCI). The goal is to understand neurological recovery post-SCI and improve arm/hand function hindered by spasticity.
What are the potential side effects?
Since this trial involves non-invasive acoustic stimuli rather than medication or surgery, significant side effects are not anticipated. However, participants may experience discomfort from startle responses.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 75 years old.
Select...
I have had a spinal cord injury for at least one year.
Select...
I have a partial spinal cord injury above my waist.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a head injury or stroke in the past.
Select...
I have a spinal condition like stenosis, spina bifida, or a herniated disk.
Select...
I am taking medication that affects my brain and could make seizures more likely.
Select...
I do not have unmanaged lung, heart, or bone problems.
Select...
I had a condition before my spinal cord injury that made it hard for me to exercise.
Select...
I have a history of seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
10-meter walk test
Graded and Redefined Assessment of Strength, Sensibility and Prehension (GRASSP).
Ipsilateral MEPs (iMEPs)
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Aim 2Experimental Treatment1 Intervention
To accomplish this aim, we will use a randomized crossover design study with spastic SCI participants receiving a single intervention combining non-invasive acoustic stimuli (Startle) or sham-Startle with motor training to enhance cortico- and reticulo-spinal contribution, separated by \~2 weeks.
Visit 1 and Visit 2
Single intervention of:
Startle + exercise training OR sham-Startle + exercise training
Pre and post measurements:
* MVCs
* MEP recruitment curves
* iMEPs
* StartReact
* Participant reported spasticity
* MAS
* PSAD
* KINARM
* Neuromechanical hand and/or leg testing
* GRASSP
* TRI-HFT
* 10-meter walk test
* Pendulum Test
Group II: Aim 1Experimental Treatment1 Intervention
To accomplish this aim, we will conduct one experiment in two sessions separated by 2- 3 days using a crossover design. Participants will be assigned into one of three groups: spastic SCI, non-spastic SCI, and controls. We expect that people enrolled in Aim 1 will complete 2 visits within 1 week.
Visit 1 Measurements:
* MVCs
* MEP Recruitment Curves
* iMEPs
* StartReact
Visit 2 Measurements:
* Participant Reported Spasticity
* MAS
* PSAD
* KINARM
* MRI of brain and spinal cord
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
208 Previous Clinical Trials
17,905 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a certain score on the MAS assessment.I have had a head injury or stroke in the past.I can bend and straighten my elbow, knee, or ankle on my own.You have a pacemaker.You have a history of severe depression or psychosis, or have problems with your memory and thinking.I am between 18 and 75 years old.I can reach for and grab things.I am either male or female.I have a spinal condition like stenosis, spina bifida, or a herniated disk.I have had a spinal cord injury for at least one year.You have a score of 0 or 1 on the Modified Ashworth Scale (MAS) if you have spinal cord injury and do not have muscle stiffness.You have a metal plate in your skull.I can bend and straighten my elbow, knee, or ankle.You use your right hand for activities.I am taking medication that affects my brain and could make seizures more likely.I have a partial spinal cord injury above my waist.I do not have unmanaged lung, heart, or bone problems.I had a condition before my spinal cord injury that made it hard for me to exercise.I have a history of seizures.
Research Study Groups:
This trial has the following groups:- Group 1: Aim 1
- Group 2: Aim 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger